Real-Time Vessel Flow Control System with Adaptive Occlusion

A novel vessel flow control system that utilizes real-time monitoring and adaptive occlusion to optimize treatment outcomes for afflicted vessels in mammalian patients.

The original patent's vessel flow control devices and methods have limitations in achieving optimal treatment outcomes due to the lack of real-time feedback and adaptive occlusion. The present inventive concept addresses these limitations by introducing a system that continuously monitors vessel blood flow and pressure, and adjusts the occlusion factor in real-time to ensure optimal treatment outcomes.

The real-time vessel flow control system comprises a vessel flow control device having a variable occlusion element with an internal volume that is adjustable in real-time based on continuous monitoring of vessel blood flow and pressure. The system includes sensors that monitor vessel blood pressure and flow rate, providing real-time feedback to adjust the occlusion factor. The occlusion element can be self-expanding, and its shape can change in response to changes in vessel blood pressure. The system can also include multiple adjustable occlusion elements that can be independently controlled to optimize blood flow and pressure within different regions of the vessel. Additionally, the occlusion element can have a dynamic surface texture that changes in response to changes in vessel blood flow and pressure, enhancing blood flow and promoting healing of the afflicted vessel.

The novelty of the present inventive concept lies in the real-time adaptive occlusion and continuous monitoring of vessel blood flow and pressure, which enables optimal treatment outcomes. The inventive step is the integration of real-time feedback and adaptive occlusion, which overcomes the limitations of the original patent's devices and methods.

Alternative embodiments of the inventive concept could include using different types of sensors, such as optical or ultrasonic sensors, to monitor vessel blood flow and pressure. The occlusion element could also be made of different materials, such as shape-memory alloys or polymers, to achieve the desired properties. Additionally, the system could be integrated with other medical devices, such as stents or catheters, to provide a more comprehensive treatment solution.

The real-time vessel flow control system has significant commercial potential in the medical device industry, particularly in the treatment of cardiovascular diseases. The target market includes hospitals, clinics, and medical research institutions that specialize in vascular treatments. The system's ability to optimize treatment outcomes and reduce complications could lead to increased adoption and revenue growth in the market.